Home » Topics » BioWorld Science

BioWorld Science
RSS

New PEGylated IL-2 with improved pharmacologic properties specifically activates and expands Tregs

Nov. 18, 2019

New Smo antagonist shows antitumor activity in medulloblastoma and cholangiocarcinoma animal models

Nov. 18, 2019

HPN-328 targeting DLL3 shows preclinical efficacy and safety for immunotherapy in SCLC

Nov. 18, 2019

Roche presents first-in-human data for RO-7062931

Nov. 18, 2019

resTORbio stops development of RTB-101 for clinically symptomatic respiratory illness

Nov. 15, 2019

Interim data presented from phase I study of TK-216 in Ewing's sarcoma

Nov. 15, 2019

FDA grants accelerated approval to Brukinsa for mantle cell lymphoma

Nov. 15, 2019

FDA approves Fetroja for complicated urinary tract infections

Nov. 15, 2019

I-Mab obtains Chinese IND clearance for phase I trials of TJM-2 in rheumatoid arthritis

Nov. 15, 2019

Phase II study of AV-101 in major depressive disorder does not meet primary endpoint

Nov. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...